Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 33, 2003 - Issue 9
75
Views
32
CrossRef citations to date
0
Altmetric
Research Article

Dose-response studies on the induction of liver cytochromes P4501A1 and 1B1 by polycyclic aromatic hydrocarbons in arylhydrocarbon-responsive C57BL/6J mice

, , , , , , , & show all
Pages 957-971 | Published online: 22 Sep 2008

Reference

  • AMIN, S., KRZEMINSKI, J., RIVENSON, A., KURTZKE, C., HECHT, S. S. and EL-BAYOUMY, K., 1995, Mammary carcinogenicity in female CD rats of fjord region diol epoxides of benzo[c]phenanthrene, benzo[g]chrysene and dibenzo[aflpyrene. Carcinogenesis, 16, 1971–1974.
  • BUTERS, J. T. M., MAHADEVAN, B., QUINTANILLA-MARTINEZ, L., GONZALEZ, F. J., GREIM, H., BAIRD, W. M. and Luoi, A., 2002, Cytochrome P450 1B1 determines susceptibility to dibenzo[a.flpyrene-induced tumor formation. Chemical Research in Toxicology, 15, 1127–1135.
  • BUTERS, J. T. M., SAKAI, S., RICHTER, T., PINEAU, T., ALEXANDER, D. L., SAVAS, U., DOEHMER, J., WARD, J. M., JEFCOATE, C. R. and GONZALEZ, F. J., 1999, Cytochrome P450 CYP1B1 determines susceptibility to 7,12-dimethylbenz[a]anthracene-induced lymphomas. Proceedings of the National Academy of Sciences, USA, 96, 1977–1982.
  • CONNEY, A. H., 1982, Induction of microsomal enzymes by foreign chemicals and carcinogenesis by polycyclic aromatic hydrocarbons: G. H. A. Clowes Memorial Lecture. Cancer Research, 42, 4875–4917.
  • FREUDENTHAL, R. I. and JONES, P., 1976, Carcinogenesis. Polynuclear Aromatic Hydrocarbons. Chemistry, Metabolism, and Carcinogenesis (New York: Raven), pp. 1–450.
  • GELBOIN, H. V., 1980, Benzo[a]pyrene metabolism, activation, and carcinogenesis: role and regulation of mixed-function oxidases and related enzymes. Physiology Reviews, 60, 1107–1166.
  • GUENGERICH, F. P., 1989, Microsomal enzymes involved in toxicology, analysis and separation. In A. W. Hayes (ed.), Principles and Methods of Toxicology, 2nd edn (New York: Raven), pp. 777–814.
  • GUENGERICH, F. P. and SHIMADA, T., 1991, Oxidation of toxic and carcinogenic chemicals by human cytochrome P-450 enzymes. Chemical Research in Toxicology, 4, 391–407.
  • HANKINSON, 0., 1995, The aryl hydrocarbon receptor complex. Annual Reviews of Pharmacology and Toxicology, 35, 307–340.
  • HECHT, S. S., 1999, Tobacco smoke carcinogens and lung cancer. Journal of the National Cancer Institute, 91, 1194–1210.
  • HECHT, S. S., AMIN, S., LIN, J.-M., RIVENSON, A., KURTZKE, C. and EL-BAYOUMY, K., 1995, Mammary carcinogenicity in female CD rats of a diol epoxide metabolite of fiuoranthene, a commonly occurring environmental pollutant. Carcinogenesis, 16, 1433–1435.
  • HIGGINBOTHAM, S., RAMAKRISHNA, N. V. S., JOHANSSON, S. L., ROGAN, E. G. and CAVALIERI, E. L., 1993, Tumor-initiating activity and carcinogenicity of dibenzo[Olpyrene versus 7,12-dimethylbenz[a]anthracene and benzo[a]pyrene at low doses in mouse skin. Carcinogenesis, 14, 875–878.
  • Hu, K. and BUNCE, N. J., 1999, Metabolism of polychlorinated dibenzo-p-dioxins and related dioxin-like compounds. Journal of Toxicology and Environmental Health, 2, 183–210.
  • LITCHFIELD, J. T. and WILCOXON, F., 1949, A simplified method of evaluating dose—effect experiments. Journal of Pharmacology and Experimental Therapeutics, 96, 99–113.
  • LOWRY, 0. H., ROSEBROUGH, N. J., FARR, A. L. and RANDALL, R. J., 1951, Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry, 193, 265–275.
  • MIMURA, J., YAMASHITA, K., NAKAMURA, K., MORITA, M., TAKAGI, T. N., NAKAO, K., EMA, M., SOGAWA, K., YASUDA, M., KATSUKI, M. and FUJII-KURIYAMA, Y., 1997, Loss of teratogenic response to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in mice lacking the Ah (dioxin) receptor. Genes to Cells, 2, 645–654.
  • NESNOW, S., DAVIS, C., PADGETT, W., GEORGE, M., LAMBERT, G., MEYERS, F., ALLISON, J., ADAMS, L. and KING, L. C., 1998, Metabolic activation of racemic and enantiomeric trans-8,9-dihydroxy-8,9-dihydrodibenzo[O]pyrene (dibenzo[def,p]chrysene) to dibenzo[O]pyrene-bis-dihydrodiols by induced rat liver microsomes and a recombinant human P450 1A1 system: the role of the K-region-derived metabolic intermediates in the formation of dibenzo[O]pyrene—DNA adducts. Chemical Research in Toxicology, 11, 1596–1607.
  • NISBET, I. C. T. and LAG0Y, P. K., 1992, Toxic equivalency factors (TEFs) for polycyclic aromatic hydrocarbons (PAHs). Regulations in Toxicology and Pharmacology, 16, 290–300.
  • OMURA, T. and SATO, R., 1964, The carbon monoxide-binding pigment of liver microsomes. I. Evidence for its hemoprotein nature. Journal of Biological Chemistry, 239, 2370-2378. PELKONEN, 0. and NEBERT, D. W., 1982, Metabolism of polycyclic aromatic hydrocarbons: etiologic role in carcinogenesis. Pharmacological Reviews, 34, 189–222.
  • PETRY, T., SCHMID, P. and SCHLATTER, C., 1996, The use of toxic equivalency factors in assessing occupational and environmental health risk associated with exposure to airborne mixtures of polycyclic aromatic hydrocarbons (PAHs). Chemosphere, 32, 639–648.
  • POSTLIND, H., Vu, T. P., TUKEY, R. H. and QUATTROCHI, L. C., 1993, Response of human CYP1-luciferase plasmids to 2,3,7,8-tetrachlorodibenzo-p-dioxin and polycyclic aromatic hydro-carbons. Toxicology and Applied Pharmacology, 118, 255–262.
  • REEVES, W. R., BARHOUMI, R., BURGHARDT, R. C., LEMKE, S. L., MAYURA, K., MCDONALD, T. J., PHILLIPS, T. D. and DONNELLY, K. C., 2001, Evaluation of methods for predicting the toxicity of polycyclic aromatic hydrocarbon mixtures. Environmental and Science Technology, 35, 1630–1636.
  • SAVAS, U., CARSTENS, C.-P. and JEF0DATE, C. R., 1997, Recombinant Mouse CYP1B1 expressed in Escherichia coli exhibits selective binding by polycyclic hydrocarbons and metabolism which parallels C3H10T1/2 cell microsomes, but differs from human recombinant CYP1B1. Archives of Biochemistry and Biophysics, 347, 181–192.
  • SHIMADA, T., GILLAM, E. M. J., ODA, Y., TSUMURA, F., SUTTER, T. R., GUENGERICH, F. P. and INouE, K., 1999, Metabolism of benzo[a]pyrene to trans-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene by recombinant human cytochrome P450 1B1 and purified liver epoxide hydrolase. Chemical Research in Toxicology, 12, 623–629.
  • SHIMADA, T., HAYES, C. L., YAMAZAKI, H., AMIN, S., HECHT, S. S., GUENGERICH, F. P. and SUTTER, T. R., 1996, Activation of chemically diverse procarcinogens by human cytochrome P450 1B1. Cancer Research, 56, 2979–2984.
  • SHIMADA, T., INouE, K., SUZUKI, Y., KAWAI, T., AZUMA, E., NAKAJIMA, T., SHINDO, M., KUROSE, K., SUGIE, A., YAMAGISHI, Y., FUJII-KURIYAMA, Y. and HASHIMOTO, M., 2002a, Arylhydrocarbon receptor-dependent induction of liver and lung cytochromes P450 1A1, 1A2, and 1B1 by polycyclic aromatic hydrocarbons and polychlorinated biphenyls in genetically engineered C57BL/6J mice. Carcinogenesis, 23, 1199–1207.
  • SHIMADA, T., IWASAKI, M., MARTIN, M. V. and GUENGERICH, F. P., 1989, Human liver microsomal cytochrome P-450 enzymes involved in the bioactivation of procarcinogens detected by umu gene response in Salmonella typhimurium TA1535/pSK1002. Cancer Research, 49, 3218–3228.
  • SHIMADA, T., ODA, Y., GILLAM, E. M. J., GUENGERICH, F. P. and INouE, K., 2001a, Metabolic activation of polycyclic aromatic hydrocarbons and other procarcinogens by cytochromes P450 1A1 and P450 1B1 allelic variants and other human cytochromes P450 in Salmonella typhimurium NM2009. Drug Metabolism and Disposition, 29, 1176–1182.
  • SHIMADA, T., ODA, Y., YAMAZAKI, H., MIMURA, M. and GUENGERICH, F. P., 1994, SOS function tests for studies of chemical carcinogenesis using Salmonella typhimurium TA1535/pSK1002, NM2009, and NM3009. In K. W. Adolph (ed.), Methods in Molecular Genetics, vol. 5: Gene and Chromosome Analysis Part C (San Diego: Academic Press), pp. 342–355.
  • SHIMADA, T. and OKUDA, Y., 1988, Metabolic activation of environmental carcinogens and mutagens by human liver microsomes: role of cytochrome P-450 homologous to a 3-methylcholanthrene-inducible isozyme in rat liver. Biochemical Pharmacology, 37, 459–465.
  • SHIMADA, T., SUGIE, A., SHINDO, M., NAKAJIMA, T., AZUMA, E., HASHIMOTO, M. and INouE, K., 2002b, Tissue-specific induction of cytochromes P450 1A1 and 1B1 by polycyclic aromatic hydrocarbons and polychlorinated biphenyls in engineered C57BL/6J mice of Arylhydrocarbon Receptor gene. Toxicology and Applied Pharmacology, 187, 1–10.
  • SHIMADA, T., WATANABE, J., GUENGERICH, F. P., INouE, K. and GILLAM, E. M. J., 2001b, Specificity of 1713-estradiol and benzo[a]pyrene oxidations by polymorphic human cytochrome P450 1B1 variants substituted at residues 48, 119 and 432. Xenobiotica, 31, 163–176.
  • SHIMADA, T., WUNSCH, R. M., HANNA, I. H., SUTTER, T. R., GUENGERICH, F. P. and GILLAM, E. M. J., 1998a, Recombinant human cytochrome P450 1B1 expression in Escherichia coli. Archives of Biochemistry and Biophysics, 357, 111–120.
  • SHIMADA, T., YAMAZAKI, H., FOROOZESH, M., HOPKINS, N. E., ALWORTH, W. L. and GUENGERICH, F. P., 1998b, Selectivity of polycyclic inhibitors for human cytochromes P450 1A1, 1A2, and 1B1. Chemical Research in Toxicology, 11, 1048–1056.
  • SHIMIZU, Y., NAKATSURU, Y., ICHINOSE, M., TAKAHASHI, Y., KUME, H., MIMURA, J., FUJII-KURIYAMA, Y. and IsHIKAwA, T., 2000, Benzo[a]pyrene carcinogenicity is lost in mice lacking the aryl hydrocarbon receptor. Proceedings of the National Academy of Sciences, USA, 97, 779–782.
  • SHou, M., KRAUSZ, K. W., GONZALEZ, F. J. and GELBOIN, H. V., 1996, Metabolic activation of the potent carcinogen dibenzo[aj]anthracene by cDNA-expressed human cytochromes P450. Archives of Biochemistry and Biophysics, 328, 201–207.
  • SJOGREN, M., EHRENBERG, L. and RANNUG, U., 1996, Relevance of different biological assays in assessing initiating and promoting properties of polycyclic aromatic hydrocarbons with respect ton carcinogenic potency. Mutation Research, 358, 97–112.
  • WHITLOCK, J. P., 1999, Induction of cytochrome P4501A1. Annual Reviews of Pharmacology and Toxicology, 39, 103–125.
  • YAMAZAKI, H., TANAKA, M. and SHIMADA, T., 1999, Highly sensitive high-performance liquid chromatographic assay for coumarin 7-hydroxylation and 7-ethoxycoumarin 0-deethylation by human liver cytochrome P450 enzymes. Journal of Chromatography B, 721, 13–19.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.